What does Yosemite invest in?
Yosemite invests most often at Seed and Series B (100% of the rounds on record), in sectors such as Cancer.

United States · Investor
Last cheque observed Oct 2026; 4 cheques on record.
Deploying nowNew fund, Jan 2026VC firm
2 cheques in the last 12 months
Mostly Seed and Series B: 100% of its rounds
Led 3 rounds
Yosemite aims to make cancer non-lethal within our lifetimeFrom their own website
Every round we can evidence, newest first4 appearances
2 rounds
2 rounds
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
Named by the firm itself, on a filing, its Form ADV or its company registration4 named
We also hold 4 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
From the firm's own filings with the SEC, which it must file accurately by law
Funds on its Form ADV
1 private fund, $233M in gross assets · filed May 2024
The latest companies Yosemite put money into.
Yosemite invests most often at Seed and Series B (100% of the rounds on record), in sectors such as Cancer.
4 investments on record, 2 of them in the last 12 months, and it led 3. The most recent was in Oct 2026.
Its most recent investments on record: Skopos Bio (Seed, Oct 2026), HistoSonics (Jun 2026) and Fourier Health (Seed, Oct 2025).
The median round it joins is $12M.
Yes: it is actively investing, with 2 investments in the last 12 months.
Yosemite is a VC firm based in San Francisco, United States.
About $1.1B, as regulatory assets under management (Oct 2026).
Its latest fund filing with the SEC was in Jan 2026.
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it